Fogo de Chão, Inc. Reports Preliminary Results for the Fiscal Fourth Quarter of 2017
Jan 08, 2018 13:31 pm UTC| Business
DALLAS, Jan. 08, 2018 -- Fogo de Chão, Inc. (“Fogo” or the “Company”) (NASDAQ:FOGO) today announced preliminary, unaudited financial results for its fiscal fourth quarter ended December 31, 2017. Fourth quarter 2017...
The Chefs’ Warehouse, Inc. Announces Preliminary Full Year 2018 Guidance
Jan 08, 2018 13:31 pm UTC| Business
RIDGEFIELD, Conn., Jan. 08, 2018 -- The Chefs’ Warehouse, Inc. (NASDAQ:CHEF), a premier distributor of specialty food products in the United States and Canada, today announced its preliminary outlook for full year...
Jan 08, 2018 13:31 pm UTC| Business
BOSTON and LOS ANGELES, Jan. 08, 2018 -- Gordon Brothers, a global advisory, restructuring and investment firm specializing in the industrial, consumer products and retail sectors, has been retained by Reed’s, Inc....
ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial
Jan 08, 2018 13:31 pm UTC| Business
-------------------------------------------------------------------------------------------------- GENETIC-AF Evaluating Gencaro as Potentially First Genetically-Targeted Treatment for Atrial...
Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.
Jan 08, 2018 13:31 pm UTC| Business
DURHAM, N.C., Jan. 08, 2018 -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision...
Iconic Dish Propels Camellia Brand
Jan 08, 2018 13:31 pm UTC| Business
NEW ORLEANS, Jan. 08, 2018 -- Creamy, hearty, delicious and thanks to Publix Stores in six states (AL, TN, GA, SC, NC and VA) and Tom Thumb in Texas, consumers can now enjoy New Orleans-style Red Beans and Rice made...
Jan 08, 2018 13:31 pm UTC| Business
Royalty Pharma acquires Royalty Rights on Global Net Sales of Sacituzumab Govitecan (IMMU-132) Across All Indications for $175 Million Royalty Pharma Acquires $75 Million of Immunomedics Common Stock at $17.15 per share,...